Literature DB >> 6221679

Kinetics of the delayed-type hypersensitivity response in tuberculous guinea pigs and mice tested with several mycobacterial antigen preparations.

F M Collins.   

Abstract

Specific pathogen-free B6D2 mice and Hartley guinea pigs were infected subcutaneously with selected strains of Mycobacterium tuberculosis, M. bovis, M. kansasii, the MAIS complex, M. nonchromogenicum, and M. vaccae, and the in vivo growth behavior of the organisms was correlated with the level of tuberculin hypersensitivity and immunity to tuberculosis that subsequently developed. The peak level of tuberculin hypersensitivity varied depending on the host species, the immunogenicity of the infecting organism, and the dose and route of inoculation. However, the skin or footpad swelling profiles observed in mice and guinea pigs sensitized with live or heat-killed M. tuberculosis (persistor) or M. vaccae (nonpersistor) were very similar when a soluble test antigen was used, peaking between 24 and 36 h and already declining by 48 h. However, if sonically disrupted or whole-cell antigens were used, the swelling response was skewed significantly, with some residual swelling still present at 72 h. However, no evidence for two distinct cellular hypersensitivity responses was obtained in either mice or guinea pigs, regardless of the growth behavior of the mycobacteria in vivo.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6221679     DOI: 10.1164/arrd.1983.127.5.599

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  5 in total

1.  Low-dose aerosol infection model for testing drugs for efficacy against Mycobacterium tuberculosis.

Authors:  B P Kelly; S K Furney; M T Jessen; I M Orme
Journal:  Antimicrob Agents Chemother       Date:  1996-12       Impact factor: 5.191

2.  Protective immunity to experimental tuberculosis by mannophosphoinositides of mycobacteria.

Authors:  P K Mehta; G K Khuller
Journal:  Med Microbiol Immunol       Date:  1988       Impact factor: 3.402

Review 3.  Mycobacterial disease, immunosuppression, and acquired immunodeficiency syndrome.

Authors:  F M Collins
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

4.  Biological activity of protein antigens isolated from Mycobacterium tuberculosis culture filtrate.

Authors:  F M Collins; J R Lamb; D B Young
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

5.  Crossprotection against nontuberculous mycobacterial infections by Mycobacterium tuberculosis memory immune T lymphocytes.

Authors:  I M Orme; F M Collins
Journal:  J Exp Med       Date:  1986-01-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.